Skip to main content

Research Repository

Advanced Search

Decreased interferon-? induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis

Tanasescu, Radu; Midgley, Angela; Robins, R. Adrian; Constantinescu, Cris S.

Decreased interferon-? induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis Thumbnail


Authors

Radu Tanasescu

Angela Midgley

R. Adrian Robins

Cris S. Constantinescu



Abstract

Objectives. Interferon-? (IFN-?) is used in the treatment of multiple sclerosis (MS). IFN-? activation of signal transduction and activation of transcription (STAT)-4 is linked to its immunomodulatory effects. Previous studies suggest a type I IFN deficit in immune cells of MS patients, but data on interferon-?/? receptor (IFNAR) expression and the relationship with treatment response are conflicting. Here we compare IFN-?-mediated STAT4 activation in immune cells of untreated MS patients and controls.
Materials & methods. Peripheral blood mononuclear cells (PBMC) from 27 untreated patients with relapsing MS, obtained before the initiation of IFN-? treatment, and 12 matched controls were treated in vitro with IFN-?. Total and phosphorylated STAT4 (pSTAT4) and IFNAR were measured by flow cytometry and quantitative PCR. The patients were followed-up for 5 years.
Results. pSTAT4 induction by IFN-? was lower in MS patients than in controls, as was expression of IFNAR. pSTAT4 expression did not correlate with the clinical outcome at five years, measured by EDSS change. There was a negative correlation between the baseline IFNAR1 mRNA levels and relapse rate.
Conclusions. The results suggest decreased IFN-? responsiveness in MS patients, associated with reduced STAT4 activation and reduced IFNAR expression. This reduced responsiveness does not appear to affect the long term clinical outcome of IFN-? treatment.

Citation

Tanasescu, R., Midgley, A., Robins, R. A., & Constantinescu, C. S. (in press). Decreased interferon-? induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis. Acta Neurologica Scandinavica, https://doi.org/10.1111/ane.12715

Journal Article Type Article
Acceptance Date Nov 11, 2016
Online Publication Date Dec 5, 2016
Deposit Date Feb 2, 2017
Publicly Available Date Feb 2, 2017
Journal Acta Neurologica Scandinavica
Print ISSN 0001-6314
Electronic ISSN 1600-0404
Publisher Wiley
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1111/ane.12715
Public URL https://nottingham-repository.worktribe.com/output/836533
Publisher URL http://onlinelibrary.wiley.com/doi/10.1111/ane.12715/full

Files





Downloadable Citations